Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 6 | 2015 | 546 | 1.080 |
Why?
|
| Glutamic Acid | 3 | 2015 | 115 | 1.030 |
Why?
|
| Neurons | 8 | 2018 | 1130 | 0.840 |
Why?
|
| Synapses | 4 | 2008 | 173 | 0.540 |
Why?
|
| Cyclic AMP | 1 | 2015 | 125 | 0.500 |
Why?
|
| Synaptic Transmission | 2 | 2014 | 141 | 0.500 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2014 | 9 | 0.490 |
Why?
|
| Presynaptic Terminals | 2 | 2014 | 52 | 0.490 |
Why?
|
| Cerebellum | 2 | 2005 | 69 | 0.480 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2005 | 58 | 0.480 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 70 | 0.470 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2005 | 70 | 0.430 |
Why?
|
| Receptors, GABA | 2 | 2001 | 22 | 0.410 |
Why?
|
| Receptors, GABA-A | 4 | 2003 | 60 | 0.360 |
Why?
|
| Calcium Channels | 1 | 2008 | 72 | 0.310 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 102 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 1530 | 0.270 |
Why?
|
| Egtazic Acid | 1 | 2005 | 14 | 0.270 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 19 | 0.260 |
Why?
|
| Purkinje Cells | 1 | 2005 | 19 | 0.260 |
Why?
|
| Cells, Cultured | 7 | 2015 | 1442 | 0.260 |
Why?
|
| Phenylurea Compounds | 2 | 2015 | 18 | 0.260 |
Why?
|
| Signal Transduction | 3 | 2015 | 1802 | 0.250 |
Why?
|
| Animals | 12 | 2022 | 14307 | 0.220 |
Why?
|
| Receptors, GABA-B | 1 | 2001 | 11 | 0.200 |
Why?
|
| Neural Inhibition | 3 | 2008 | 47 | 0.200 |
Why?
|
| Genetic Vectors | 1 | 2001 | 154 | 0.200 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 124 | 0.200 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 176 | 0.190 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 214 | 0.190 |
Why?
|
| Mice | 7 | 2022 | 5668 | 0.180 |
Why?
|
| Gene Expression | 1 | 2001 | 639 | 0.160 |
Why?
|
| Synapsins | 2 | 2015 | 7 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 128 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2018 | 137 | 0.150 |
Why?
|
| Cholinergic Agents | 1 | 2015 | 7 | 0.130 |
Why?
|
| Isoxazoles | 1 | 2015 | 11 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2015 | 35 | 0.130 |
Why?
|
| Choline | 1 | 2015 | 57 | 0.130 |
Why?
|
| Receptor, trkB | 2 | 2005 | 14 | 0.120 |
Why?
|
| Evoked Potentials | 2 | 2005 | 83 | 0.120 |
Why?
|
| Benzamides | 1 | 2014 | 76 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2014 | 897 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2014 | 423 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 859 | 0.110 |
Why?
|
| Calcium | 1 | 2015 | 445 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2015 | 878 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 968 | 0.090 |
Why?
|
| Synaptic Vesicles | 1 | 2008 | 29 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 1534 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2005 | 323 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2008 | 121 | 0.070 |
Why?
|
| Median Eminence | 1 | 2005 | 10 | 0.070 |
Why?
|
| Neocortex | 1 | 2005 | 26 | 0.070 |
Why?
|
| Rats | 3 | 2001 | 3261 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 984 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 396 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2005 | 53 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2005 | 177 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 171 | 0.060 |
Why?
|
| Humans | 4 | 2022 | 34853 | 0.060 |
Why?
|
| Esophagectomy | 1 | 2022 | 6 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2022 | 63 | 0.050 |
Why?
|
| Cell Movement | 1 | 2005 | 545 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2022 | 67 | 0.050 |
Why?
|
| Ruthenium Red | 1 | 2001 | 4 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2001 | 10 | 0.050 |
Why?
|
| Bicuculline | 1 | 2001 | 14 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 57 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1007 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2001 | 19 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 608 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2001 | 59 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 47 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2001 | 93 | 0.050 |
Why?
|
| Forecasting | 1 | 2001 | 124 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 92 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2001 | 132 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2001 | 175 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2001 | 85 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 286 | 0.050 |
Why?
|
| Cell Death | 1 | 2001 | 260 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2000 | 33 | 0.050 |
Why?
|
| Action Potentials | 1 | 2001 | 219 | 0.040 |
Why?
|
| Male | 2 | 2018 | 18870 | 0.040 |
Why?
|
| Female | 2 | 2018 | 19873 | 0.040 |
Why?
|
| Amygdala | 1 | 2018 | 110 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2018 | 304 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 358 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 705 | 0.030 |
Why?
|
| Brain | 1 | 2018 | 1268 | 0.020 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 2008 | 21 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2008 | 31 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 75 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 200 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 496 | 0.020 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2000 | 6 | 0.010 |
Why?
|
| Staurosporine | 1 | 2000 | 35 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2000 | 37 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2000 | 137 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2000 | 110 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 834 | 0.010 |
Why?
|
| Time Factors | 1 | 2000 | 1681 | 0.010 |
Why?
|